Emergency management of immune-related toxicity Review


Authors: Cooksley, T.; Stutman, R.; Klotz, A.
Review Title: Emergency management of immune-related toxicity
Abstract: PURPOSE OF REVIEW: Emergency presentations in patients treated with immune checkpoint inhibitors (ICIs) are a clinical challenge. Clinicians need to be vigilant in diagnosing and treating immune-mediated toxicities. In this review, we consider the approach to managing an acutely unwell patient being treated with ICIs presenting as an emergency. RECENT FINDINGS: A minority of acutely unwell patients treated with ICIs will have an immune-mediated toxicity. Early recognition and intervention in those with immune-mediated toxicity can reduce the duration and severity of the complications. The use of early immunosuppressive agents along corticosteroid therapy may improve outcomes in patients with life-threatening immune-mediated toxicity. SUMMARY: Individualized management of immune-mediated toxicities is a key challenge for emergency oncology services; this has become part of routine cancer care.
Journal Title: Current Opinion in Oncology
Volume: 32
Issue: 4
ISSN: 1040-8746
Publisher: Lippincott Williams & Wilkins  
Date Published: 2020-07-01
Start Page: 274
End Page: 281
Language: English
DOI: 10.1097/cco.0000000000000635
PUBMED: 32541313
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 July 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Adam Klotz
    21 Klotz